Avai Bio, Inc.
AVAI· OTC
AVAIAvai Bio, Inc.
Filed Nov 14, 2025 · 10-Q · 45 days after period end · 0001740797-25-000054
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2020 |
|---|---|---|---|---|
| Net Income | -$453.02K | -$623.05K | -$399.62K | $50.46K |
| EPS Diluted | — | — | — | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 14, 2025 · 45 d after period end
